Interactive Investor
>>

Orphazyme AS ADR (NASDAQ:ORPH) Share Price

ORPH

Orphazyme AS ADR

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Orphazyme AS is a late-stage biopharmaceutical company harnessing the amplification of Heat Shock Proteins. It is engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for four severe orphan diseases: Niemann-Pick disease Type C (NPC), Gaucher disease, Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases.

NASDAQ:ORPH

US6873051022

USD

Loading...

Loading Comparison

Latest ORPH News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News